{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:44:50Z","timestamp":1795085090674,"version":"4.10.2"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Increased intracellular toxicity due to an imbalance in copper homeostasis caused by copper ion accumulation could regulate the rate of cancer cell growth and proliferation. The goal of this study was to create a novel Cuproptosis-related lncRNA signature that may be utilized to predict survival and immunotherapy in HCC patients. Cuproptosis-associated lncRNAs and differentially expressed lncRNAs between HCC tumor tissue and normal tissue were discovered first. By LASSO-Cox analysis, the overlapping lncRNAs were then utilized to build a Cuproptosis-associated lncRNA signature, which might be used to predict patient prognosis and responsiveness to immune checkpoint blockade (ICB) therapy. Differences in the infiltration of immune cell subpopulations between high and low-risk score subgroups were also analyzed. Moreover, a nomogram based on the Cuproptosis-associated lncRNA signature and clinical features was developed and demonstrated to have good predictive potential. Finally, qRT-PCR was performed in HerpG2 and MHCC-97H cell lines to explore whether these lncRNAs were indeed involved in the process of Cuproptosis. In summary, we created a prognostic lncRNA profile linked to Cuproptosis to forecast response to immunotherapy, which may provide a new potential non-apoptotic therapeutic perspective for HCC patients.<\/jats:p>","DOI":"10.1038\/s41598-022-15251-1","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:03:05Z","timestamp":1656997385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":170,"title":["A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma"],"prefix":"10.1038","volume":"12","author":[{"given":"Genhao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"issue":"3","key":"15251_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nchembio.72","volume":"4","author":"BE Kim","year":"2008","unstructured":"Kim, B. E., Nevitt, T. & Thiele, D. J. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 4(3), 176\u2013185 (2008).","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"15251_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cbpa.2010.01.003","volume":"14","author":"S Lutsenko","year":"2010","unstructured":"Lutsenko, S. Human copper homeostasis: A network of interconnected pathways. Curr. Opin. Chem. Biol. 14(2), 211\u2013217 (2010).","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"15251_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"O Bandmann","year":"2015","unstructured":"Bandmann, O., Weiss, K. H. & Kaler, S. G. Wilson\u2019s disease and other neurological copper disorders. Lancet Neurol. 14(1), 103\u2013113 (2015).","journal-title":"Lancet Neurol."},{"issue":"6","key":"15251_CR4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1021\/cr040410w","volume":"106","author":"E Gaggelli","year":"2006","unstructured":"Gaggelli, E., Kozlowski, H., Valensin, D. & Valensin, G. Copper homeostasis and neurodegenerative disorders (Alzheimer\u2019s, prion, and Parkinson\u2019s diseases and amyotrophic lateral sclerosis). Chem. Rev. 106(6), 1995\u20132044 (2006).","journal-title":"Chem. Rev."},{"issue":"1","key":"15251_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12011-019-01844-x","volume":"195","author":"T Atakul","year":"2020","unstructured":"Atakul, T., Altinkaya, S. O., Abas, B. I. & Yenisey, C. Serum copper and zinc levels in patients with endometrial cancer. Biol. Trace Elem. Res. 195(1), 46\u201354 (2020).","journal-title":"Biol. Trace Elem. Res."},{"issue":"13","key":"15251_CR6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2174\/0929867323666160405111543","volume":"23","author":"A Ressnerova","year":"2016","unstructured":"Ressnerova, A. et al. Zinc and copper homeostasis in head and neck cancer: Review and meta-analysis. Curr. Med. Chem. 23(13), 1304\u20131330 (2016).","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"15251_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge, E. J. et al. Connecting copper and cancer: From transition metal signalling to metalloplasia. Nat. Rev. Cancer 22(2), 102\u2013113 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"15251_CR8","doi-asserted-by":"publisher","first-page":"111634","DOI":"10.1016\/j.jinorgbio.2021.111634","volume":"226","author":"DA da Silva","year":"2022","unstructured":"da Silva, D. A. et al. Copper in tumors and the use of copper-based compounds in cancer treatment. J. Inorg. Biochem. 226, 111634 (2022).","journal-title":"J. Inorg. Biochem."},{"issue":"6","key":"15251_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2020.04.003","volume":"25","author":"H Li","year":"2020","unstructured":"Li, H. et al. The combination of disulfiram and copper for cancer treatment. Drug Discov. Today 25(6), 1099\u20131108 (2020).","journal-title":"Drug Discov. Today"},{"issue":"6586","key":"15251_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375(6586), 1254\u20131261 (2022).","journal-title":"Science"},{"key":"15251_CR11","doi-asserted-by":"publisher","first-page":"744113","DOI":"10.3389\/fgene.2021.744113","volume":"12","author":"C Zhou","year":"2021","unstructured":"Zhou, C., Zhang, H. & Lu, L. Identification and validation of hypoxia-related lncRNA signature as a prognostic model for hepatocellular carcinoma. Front. Genet. 12, 744113 (2021).","journal-title":"Front. Genet."},{"key":"15251_CR12","doi-asserted-by":"crossref","unstructured":"Li, L., Xie, R. & Lu, G. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Biosci. Rep. 41(6), BSR20210760 (2021).","DOI":"10.1042\/BSR20210760"},{"key":"15251_CR13","doi-asserted-by":"publisher","first-page":"719175","DOI":"10.3389\/fimmu.2021.719175","volume":"12","author":"Z Xu","year":"2021","unstructured":"Xu, Z. et al. Construction of a ferroptosis-related nine-lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma. Front. Immunol. 12, 719175 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"15251_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12859-021-04123-6","volume":"22","author":"S Yang","year":"2021","unstructured":"Yang, S. et al. The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma. BMC Bioinform. 22(1), 217 (2021).","journal-title":"BMC Bioinform."},{"key":"15251_CR15","doi-asserted-by":"publisher","first-page":"645084","DOI":"10.3389\/fmolb.2021.645084","volume":"8","author":"Y Bai","year":"2021","unstructured":"Bai, Y., Lin, H., Chen, J., Wu, Y. & Yu, S. Identification of prognostic glycolysis-related lncRNA signature in tumor immune microenvironment of hepatocellular carcinoma. Front. Mol. Biosci. 8, 645084 (2021).","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"15251_CR16","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10(1), 1523 (2019).","journal-title":"Nat. Commun."},{"issue":"21","key":"15251_CR17","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Can. Res. 77(21), e108\u2013e110 (2017).","journal-title":"Can. Res."},{"issue":"1","key":"15251_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18(1), 220 (2017).","journal-title":"Genome Biol."},{"issue":"2","key":"15251_CR19","doi-asserted-by":"publisher","first-page":"118893","DOI":"10.1016\/j.bbamcr.2020.118893","volume":"1868","author":"VC Shanbhag","year":"2021","unstructured":"Shanbhag, V. C. et al. Copper metabolism as a unique vulnerability in cancer. Biochim. Biophys. Acta 1868(2), 118893 (2021).","journal-title":"Biochim. Biophys. Acta"},{"issue":"6586","key":"15251_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.abo3959","volume":"375","author":"MA Kahlson","year":"2022","unstructured":"Kahlson, M. A. & Dixon, S. J. Copper-induced cell death. Science 375(6586), 1231\u20131232 (2022).","journal-title":"Science"},{"key":"15251_CR21","doi-asserted-by":"publisher","first-page":"749134","DOI":"10.3389\/fphar.2021.749134","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. FDX1 can impact the prognosis and mediate the metabolism of lung adenocarcinoma. Front. Pharmacol. 12, 749134 (2021).","journal-title":"Front. Pharmacol."},{"issue":"7905","key":"15251_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04557-9","volume":"604","author":"A Solmonson","year":"2022","unstructured":"Solmonson, A. et al. Compartmentalized metabolism supports midgestation mammalian development. Nature 604(7905), 349\u2013353 (2022).","journal-title":"Nature"},{"key":"15251_CR23","doi-asserted-by":"publisher","first-page":"101418","DOI":"10.1016\/j.redox.2019.101418","volume":"30","author":"D Shin","year":"2020","unstructured":"Shin, D., Lee, J., You, J. H., Kim, D. & Roh, J. L. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer. Redox Biol. 30, 101418 (2020).","journal-title":"Redox Biol."},{"issue":"6","key":"15251_CR24","first-page":"1140","volume":"7","author":"WQ Goh","year":"2015","unstructured":"Goh, W. Q., Ow, G. S., Kuznetsov, V. A., Chong, S. & Lim, Y. P. DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy. Am. J. Transl. Res. 7(6), 1140\u20131151 (2015).","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"15251_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.prp.2018.12.038","volume":"215","author":"L Song","year":"2019","unstructured":"Song, L. et al. Low expression of PDHA1 predicts poor prognosis in gastric cancer. Pathol. Res. Pract. 215(3), 478\u2013482 (2019).","journal-title":"Pathol. Res. Pract."},{"issue":"5","key":"15251_CR26","first-page":"2955","volume":"40","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. miR-21-5p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer. Oncol. Rep. 40(5), 2955\u20132963 (2018).","journal-title":"Oncol. Rep."},{"issue":"12","key":"15251_CR27","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1074\/mcp.M110.000661","volume":"9","author":"Z Cai","year":"2010","unstructured":"Cai, Z. et al. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol. Cell. Proteomics 9(12), 2617\u20132628 (2010).","journal-title":"Mol. Cell. Proteomics"},{"issue":"24","key":"15251_CR28","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.7150\/jca.28040","volume":"9","author":"L Ji","year":"2018","unstructured":"Ji, L. et al. Knockout of MTF1 inhibits the epithelial to mesenchymal transition in ovarian cancer cells. J. Cancer 9(24), 4578\u20134585 (2018).","journal-title":"J. Cancer"},{"issue":"4","key":"15251_CR29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/his.14014","volume":"76","author":"BK Masisi","year":"2020","unstructured":"Masisi, B. K. et al. The role of glutaminase in cancer. Histopathology 76(4), 498\u2013508 (2020).","journal-title":"Histopathology"},{"key":"15251_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2019.09.011","volume":"467","author":"JM Mat\u00e9s","year":"2019","unstructured":"Mat\u00e9s, J. M., Campos-Sandoval, J. A., Santos-Jim\u00e9nez, J. L. & M\u00e1rquez, J. Dysregulation of glutaminase and glutamine synthetase in cancer. Cancer Lett. 467, 29\u201339 (2019).","journal-title":"Cancer Lett."},{"key":"15251_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","volume":"8","author":"R Zhao","year":"2016","unstructured":"Zhao, R., Choi, B. Y., Lee, M. H., Bode, A. M. & Dong, Z. Implications of genetic and epigenetic alterations of CDKN2A (p16(INK4a)) in cancer. EBioMedicine 8, 30\u201339 (2016).","journal-title":"EBioMedicine"},{"key":"15251_CR32","doi-asserted-by":"crossref","unstructured":"Luo, J. P., Wang, J. & Huang, J. H. CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci. Rep. 41(10), BSR20211103 (2021).","DOI":"10.1042\/BSR20211103"},{"issue":"7","key":"15251_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/1354750X.2020.1817981","volume":"25","author":"IR Silva","year":"2020","unstructured":"Silva, I. R. et al. DNA methylation changes in promoter region of CDKN2A gene in workers exposed in construction environment. Biomarkers 25(7), 594\u2013602 (2020).","journal-title":"Biomarkers"},{"key":"15251_CR34","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.omtn.2020.10.002","volume":"22","author":"W Hong","year":"2020","unstructured":"Hong, W. et al. Immune-related lncRNA to construct novel signature and predict the immune landscape of human hepatocellular carcinoma. Mol. Ther. Nucl. Acids 22, 937\u2013947 (2020).","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"15251_CR35","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3389\/fonc.2020.00780","volume":"10","author":"W Li","year":"2020","unstructured":"Li, W. et al. Identification and validation of a prognostic lncRNA signature for hepatocellular carcinoma. Front. Oncol. 10, 780 (2020).","journal-title":"Front. Oncol."},{"key":"15251_CR36","doi-asserted-by":"publisher","first-page":"759173","DOI":"10.3389\/fmolb.2021.759173","volume":"8","author":"A Huang","year":"2021","unstructured":"Huang, A., Li, T., Xie, X. & Xia, J. Computational identification of immune- and ferroptosis-related LncRNA signature for prognosis of hepatocellular carcinoma. Front. Mol. Biosci. 8, 759173 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"15251_CR37","first-page":"9997185","volume":"2021","author":"X Tang","year":"2021","unstructured":"Tang, X. et al. A novel pyroptosis-related lncRNAs signature for predicting the prognosis of kidney renal clear cell carcinoma and its associations with immunity. J. Oncol. 2021, 9997185 (2021).","journal-title":"J. Oncol."},{"key":"15251_CR38","doi-asserted-by":"publisher","first-page":"741726","DOI":"10.3389\/fsurg.2022.741726","volume":"9","author":"X Tang","year":"2022","unstructured":"Tang, X. et al. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction in papillary renal cell carcinoma. Front. Surg. 9, 741726 (2022).","journal-title":"Front. Surg."},{"key":"15251_CR39","doi-asserted-by":"publisher","first-page":"742360","DOI":"10.3389\/fsurg.2021.742360","volume":"8","author":"Z Xu","year":"2021","unstructured":"Xu, Z. et al. Comprehensive analysis of ferroptosis-related LncRNAs in breast cancer patients reveals prognostic value and relationship with tumor immune microenvironment. Front. Surg. 8, 742360 (2021).","journal-title":"Front. Surg."},{"key":"15251_CR40","doi-asserted-by":"publisher","first-page":"621809","DOI":"10.3389\/fgene.2021.621809","volume":"12","author":"S Gao","year":"2021","unstructured":"Gao, S. et al. Comprehensive analysis of lncRNA and miRNA regulatory network reveals potential prognostic non-coding RNA involved in breast cancer progression. Front. Genet. 12, 621809 (2021).","journal-title":"Front. Genet."},{"key":"15251_CR41","doi-asserted-by":"publisher","first-page":"675545","DOI":"10.3389\/fonc.2021.675545","volume":"11","author":"L Lu","year":"2021","unstructured":"Lu, L., Liu, L. P., Zhao, Q. Q., Gui, R. & Zhao, Q. Y. Identification of a ferroptosis-related LncRNA signature as a novel prognosis model for lung adenocarcinoma. Front. Oncol. 11, 675545 (2021).","journal-title":"Front. Oncol."},{"key":"15251_CR42","doi-asserted-by":"publisher","first-page":"775583","DOI":"10.3389\/fonc.2021.775583","volume":"11","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. Identification and validation of a novel six-lncRNA-based prognostic model for lung adenocarcinoma. Front. Oncol. 11, 775583 (2021).","journal-title":"Front. Oncol."},{"key":"15251_CR43","doi-asserted-by":"publisher","first-page":"779554","DOI":"10.3389\/fgene.2021.779554","volume":"12","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. A mutation-related long noncoding RNA Signature of genome instability predicts immune infiltration and hepatocellular carcinoma prognosis. Front. Genet. 12, 779554 (2021).","journal-title":"Front. Genet."},{"issue":"22","key":"15251_CR44","doi-asserted-by":"publisher","first-page":"24621","DOI":"10.18632\/aging.203698","volume":"13","author":"DP Huang","year":"2021","unstructured":"Huang, D. P. et al. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma. Aging 13(22), 24621\u201324639 (2021).","journal-title":"Aging"},{"key":"15251_CR45","doi-asserted-by":"publisher","first-page":"11607","DOI":"10.2147\/OTT.S271966","volume":"13","author":"S Xiao","year":"2020","unstructured":"Xiao, S., Huang, S. & Yang, J. Overexpression of GIHCG is associated with a poor prognosis and immune infiltration in hepatocellular carcinoma. Onco. Targets. Ther. 13, 11607\u201311619 (2020).","journal-title":"Onco. Targets. Ther."},{"issue":"11","key":"15251_CR46","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00109-016-1442-z","volume":"94","author":"CJ Sui","year":"2016","unstructured":"Sui, C. J. et al. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b\/a\/429. J. Mol. Med. 94(11), 1281\u20131296 (2016).","journal-title":"J. Mol. Med."},{"key":"15251_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fgene.2019.00025","volume":"10","author":"Z Xiang","year":"2019","unstructured":"Xiang, Z. et al. LncRNAs GIHCG and SPINT1-AS1 are crucial factors for pan-cancer cells sensitivity to lapatinib. Front. Genet. 10, 25 (2019).","journal-title":"Front. Genet."},{"issue":"24","key":"15251_CR48","first-page":"10842","volume":"23","author":"LY Fan","year":"2019","unstructured":"Fan, L. Y. et al. LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer. Eur. Rev. Med. Pharmacol. Sci. 23(24), 10842\u201310850 (2019).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"23","key":"15251_CR49","first-page":"8127","volume":"22","author":"N Yao","year":"2018","unstructured":"Yao, N., Yu, L., Zhu, B., Gan, H. Y. & Guo, B. Q. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429. Eur. Rev. Med. Pharmacol. Sci. 22(23), 8127\u20138134 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"15251_CR50","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7150\/jca.28525","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Long noncoding RNA GIHCG functions as an oncogene and serves as a serum diagnostic biomarker for cervical cancer. J. Cancer 10(3), 672\u2013681 (2019).","journal-title":"J. Cancer"},{"key":"15251_CR51","doi-asserted-by":"publisher","first-page":"13387","DOI":"10.2147\/OTT.S282348","volume":"13","author":"W Zhao","year":"2020","unstructured":"Zhao, W., Huang, Z., Liu, H. & Wang, C. LncRNA GIHCG promotes the development of esophageal cancer by modulating miR-29b-3p\/ANO1 Axis. Onco. Targets. Ther. 13, 13387\u201313400 (2020).","journal-title":"Onco. Targets. Ther."},{"key":"15251_CR52","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2147\/OTT.S192290","volume":"12","author":"X Jiang","year":"2019","unstructured":"Jiang, X., Li, Q., Zhang, S., Song, C. & Zheng, P. Long noncoding RNA GIHCG induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer. Onco. Targets. Ther. 12, 1059\u20131070 (2019).","journal-title":"Onco. Targets. Ther."},{"issue":"6","key":"15251_CR53","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1002\/mgg3.711","volume":"7","author":"G Liu","year":"2019","unstructured":"Liu, G., Jiang, Z., Qiao, M. & Wang, F. Lnc-GIHCG promotes cell proliferation and migration in gastric cancer through miR-1281 adsorption. Mol. Genet. Genomic Med. 7(6), e711 (2019).","journal-title":"Mol. Genet. Genomic Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15251-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:19:10Z","timestamp":1700785150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15251"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15251-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11325"}}